Structural elucidation of a pectin from flowers of Lonicera japonica and its antipancreatic cancer activity

[Display omitted] ⿢A new rhamnogalacturonan from flowers of Lonicera japonica is characterized.⿢Backbone is alternate 1,4-α-d-GalpA and 1,2-α-l-Rhap.⿢Branches contain T- and 1,4,6-linked β-d-Galp, T- and 1,5-linked α-l-Araf.⿢Rhamnogalacturonan might inhibit BxPC-3 and PANC-1 pancreatic cancer cells...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:International journal of biological macromolecules 2016-07, Vol.88, p.130-137
Hauptverfasser: Lin, Liyan, Wang, Peipei, Du, Zhenyun, Wang, Wucheng, Cong, Qifei, Zheng, Changping, Jin, Can, Ding, Kan, Shao, Chenghao
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:[Display omitted] ⿢A new rhamnogalacturonan from flowers of Lonicera japonica is characterized.⿢Backbone is alternate 1,4-α-d-GalpA and 1,2-α-l-Rhap.⿢Branches contain T- and 1,4,6-linked β-d-Galp, T- and 1,5-linked α-l-Araf.⿢Rhamnogalacturonan might inhibit BxPC-3 and PANC-1 pancreatic cancer cells growth. To investigate polysaccharide structure from Lonicera japonica, and study its effects on behavior of pancreatic cells, a homogenous polysaccharide, LJ-02-1, was extracted and purified from flowers of L. japonica by DEAE-cellulose and Sephacryl S-200HR column. The molecular weight was estimated to be 54kDa. Monosaccharide composition was determined to be rhamnose, galacturonic acid, galactose and arabinose in the molar ratio of 10.77:7.88:15.45:65.89 by analyzing the PMP derivatives of the monosaccharides from 2M trifluoracetic acid hydrolysis via HPLC. Based on methylation analysis, partial acid hydrolysis, and NMR spectra, the polysaccharide was elucidated to be a rhamnogalacturonan backbone and substituted partly at C-4 of rhamnose. The branches were determined to be T- and 1,4,6-linked β-d-Galp, T- and 1,5-linked α-l-Araf. The polysaccharide might inhibit BxPC-3 and PANC-1 pancreatic cancer cells growth at the concentration of 1mg/mL with inhibitory ratio of 66.7% and 52.1%, respectively.
ISSN:0141-8130
1879-0003
DOI:10.1016/j.ijbiomac.2016.03.025